CELH
Celsius Holdings, Inc.
CELH has the edge over CHA overall, supported by stronger fundamentals and stronger valuation.
CHA
Chagee Holdings Limited American Depositary Shares
CHA's outlook is improving, though it still trails on the overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
CHA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Strong |
CHA's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
CHA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $12.34 | -8.7% |
| Current | 13x | $13.51 | — |
| Fair | 15x | $15.92 | +18% |
| Expensive | 16x | $16.95 | +25% |
Historical ranges are pointers, not guarantees.
CHA has the edge over CELH in the historical PE scenario, which offers more potential upside but is not a forecast.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
CHA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CHA, with profitability improving.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
CHA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $1.04 | -37% |
| Q1 2026 | $0.73 | -65% |
| Q4 2025 | $0.91 | -55% |
| Q3 2025 | $1.43 | -17% |
| Q2 2025 | $1.64 | +12% |
| Q1 2025 | $2.08 | +93% |
| Q4 2024 | $2.01 | +209% |
| Q3 2024 | $1.73 | +344% |
CHA has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over CHA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over CHA on profitability, with a higher operating margin.
CHA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $511M | +2.2% |
| Q1 2026 | $532.2M | +4.5% |
| Q4 2025 | $446.4M | -11% |
| Q3 2025 | $481.5M | -9.4% |
| Q2 2025 | $500M | +10% |
| Q1 2025 | $509.1M | +35% |
| Q4 2024 | $500.4M | +63% |
| Q3 2024 | $531.4M | +145% |
CHA's revenue has held roughly level: $511M last quarter, up 2.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 15% | +12 points |
| Q1 2026 | 15% | -8.8 points |
| Q4 2025 | -1.2% | -21 points |
| Q3 2025 | 14% | -8.3 points |
| Q2 2025 | 3.2% | -21 points |
| Q1 2025 | 24% | -4 points |
| Q4 2024 | 19% | -4 points |
| Q3 2024 | 22% | -2.9 points |
CHA's operating margin was 15% last quarter, up 12 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over CHA on cash flow, with more consistent year-over-year improvement.
CHA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $53.8M | -32% |
| Q1 2026 | $29M | -38% |
| Q4 2025 | -$35.4M | -145% |
| Q3 2025 | $58.7M | -40% |
| Q2 2025 | $79.1M | -43% |
| Q1 2025 | $46.6M | -37% |
| Q4 2024 | $79.2M | -23% |
| Q3 2024 | $98.1M | -14% |
CHA still generates free cash flow, though less than at its 2024 peak: $106M over the past year.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over CHA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
CHA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +876K shares |
| 1 year | +5.2% | +9.5M shares |
| 3 years | +5.2% | +9.5M shares |
CHA has 193M diluted shares, up 5.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | $17.3M |
CHA hasn't bought back shares in the past year.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
CHA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -3.1x | Net Cash |
| Q1 2026 | -4.3x | Net Cash |
| Q4 2025 | -3.9x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -3.1x | Net Cash |
| Q1 2025 | -1.4x | Net Cash |
| Q4 2024 | -1.4x | Net Cash |
| Q3 2024 | -1.4x | Net Cash |
CHA has the edge over CELH on leverage, with a lower net debt burden relative to earnings.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
CHA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.4 | Neutral |
| Stochastic | 79.9 | Neutral |
CHA's weekly RSI is 61 (neutral) and its Stochastic is 80 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
CHA PE vs Consumer Defensive Sector
| Metric | CHA | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 19x | 33% below |
| PE % | 29 | 31 | 2 pts below |
CHA has the edge over CELH on valuation relative to its sector.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CHA has stronger trend alignment. CELH is above 2 of 5 weekly averages versus CHA above 3 of 3.
CHA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.0 | 12% above |
| 20 week MA | $11.5 | 17% above |
| 50 week MA | $11.4 | 18% above |
CHA is in an uptrend: it's above all three of its weekly moving averages, and 18% above its 50-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
CHA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $32.4 | $11.9 | -63% |
| 2026 YTD | $11.9 | $13.5 | +14% |
CHA has the edge over CELH on returns for 2026, with the stronger performance.